Plant derived therapeutics for the treatment of Leishmaniasis

Rupashree Sen, Mitali Chatterjee

Research output: Contribution to journalReview articlepeer-review

113 Scopus citations


Diseases caused by insect borne trypanosomatid parasites are significant, yet remain a neglected public health problem. Leishmania, a unicellular protozoan parasite is the causative organism of Leishmaniasis and is transmitted by female phlebotamine sandflies affecting millions of people worldwide. In the wake of resistance to pentavalent antimonial drugs, new therapeutic alternatives are desirable. The plant kingdom has in the past provided several affordable compounds and this review aims to provide an overview of the current status of available leishmanicidal plant derived compounds that are effective singly or in combination with conventional anti-leishmanial drugs, yet are non toxic to mammalian host cells. Furthermore, delineation of the contributory biochemical mechanisms involved in mediating their effect would help develop new chemotherapeutic approaches.

Original languageEnglish (US)
Pages (from-to)1056-1069
Number of pages14
Issue number12
StatePublished - Sep 15 2011
Externally publishedYes


  • Amastigotes
  • Antileishmanial
  • Plant derived compounds

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery
  • Complementary and alternative medicine


Dive into the research topics of 'Plant derived therapeutics for the treatment of Leishmaniasis'. Together they form a unique fingerprint.

Cite this